Recent

% | $
Quotes you view appear here for quick access.

AxoGen, Inc. Message Board

faststocks7 71 posts  |  Last Activity: Mar 29, 2016 8:16 AM Member since: Feb 21, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • MHCC shares have been crushed in the past 24 months from $1.20 to $.0003 pennies and the company recently made several bullish press releases including the hiring of their new high-powered CEO Louis Resweber who has an amazing track record of growing companies fast.

    MHCC has an impressive product line, including innovative, non-invasive products such as UroVal and VasoScan that allow for more direct patient care, as well as new cash-flow streams, at a time when doctors are searching for new ways to generate revenues.

    Additionally, the company recently announced partnership with a specialty medical laboratory group to provide full-service, comprehensive lab services. The lab's complete list of services include providing collection supplies, transportation services, express turn-around, and comprehensive on-line patient reporting.

    A small risk of only $1,000 buys about 2,000,000 shares and if shares trade back to just 5 cents, the return is over 100 times the thousand dollars or $100,000. A price of only 2 cents would equal $20,000.

    With Millennium’s business model, the diagnostic products they are getting ready to sell, the new experienced and high-powered management, and the big unmet need for them on the marketplace, this little company could easily outperform everybody’s expectations.

    LJR Capital just put out a Strong Buy recommendation.

    Sentiment: Strong Buy

  • MHCC is on the move and the percentage gains could be huge.

    Sentiment: Strong Buy

  • Chart shows clear bottom on very large volume. MHCC reported revenues increased over 400% in 2014 to over $8 million. Total market cap today is only $200,000. At only 10X revenues shares today at $0.007 should be selling at $.18 today.

    That is a 2,500% return! $1,000 investment = $25,000.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Strong Buy and Hold - MHCC 12 month price target - $.20

    Sentiment: Strong Buy

  • Recent showcase by University of Alberta researchers and press release from SEC Filings - TDM Financial explains why shares are just beginning to rise and why they will likely continue to increase in value for a long time to come.

    To see press releases, enter BLGO on Yahoo Finance and read “NEWS,”

    Buy and hold these penny shares before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • Recent showcase by University of Alberta researchers and press release from SEC Filings - TDM Financial explains why shares are just beginning to rise and why they will likely continue to increase in value for a long time to come.

    To see press releases, enter BLGO on Yahoo Finance and read “NEWS,”

    Buy and hold these penny shares before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • Recent announcement by BioLargo (BLGO) and today’s press release from SEC Filings explains why shares are just beginning to rise and why they will likely continue to increase in value for a long time to come.

    To see press releases, enter BLGO on Yahoo Finance.

    Buy and hold these penny shares before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Buy and hold these penny shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Put shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • BioLargo (BLGO) just announced that researchers conducted a confidential technical symposium August 17th at its laboratory on the University of Alberta campus in Edmonton Canada. Over 30 individuals representing a wide range of interested stakeholder groups including science, research, academia, industry, engineering, federal and provincial funding agencies, investment professionals and a leading global philanthropic organization attended. BioLargo scientists presented results of experiments and studies validating the company's technical claims that the AOS Filter is less than 1/20th the cost of the nearest technical competitor, at greater than 100 times the efficacy (disinfection), and more than 10 times faster. Researchers presented confirmation of more than 100 studies replicating these findings, demonstrating the AOS Filter's important role and high value in just about every segment of the global water industry estimated at $350 billion annually.
    Independent researchers refer to the AOS Filters disinfection rates of performance as "unprecedented". The AOS Filter combines iodine, water filter materials and electrolysis within a flow-through water filter device, generating extremely high oxidation that eliminates soluble organic contaminants that are commonly found in many types of contaminated water. Studies prove extremely high rates of disinfection, eliminating infectious biological pathogens likeSalmonella, Listeria and E.coli in water.
    This amazing AOS Filter technology is ready for commercialization and the company is ready to soar right now. Read the press release.

    Put shares in your portfolio before they are $5.00 and then $10.00 and then $20.00. This could be one of the biggest winners to come along in a long time.

    Sentiment: Strong Buy

  • faststocks7 by faststocks7 Aug 12, 2015 10:51 AM Flag

    BioLargo’s (BLGO) AOS filter is being unveiled at a showcase next week to the big industry players by researchers at the University of Alberta. The AOS Filter has been validated to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • Chart shows clear bottom on very large volume.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    New management is very strong, capable and with strong healthcare relationships. New CEO and President already grew $1.3 Billion sales in previous company.

    Revenues set to explode again in 2015.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows clear bottom on very large volume.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    New management is very strong, capable and with strong healthcare relationships. New CEO and President already grew $1.3 Billion sales in previous company.

    Revenues set to explode again in 2015.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows turnaround with big increase in volume and buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Reply to

    Predict Ten Cents Will Happen Soon

    by thomasbowles242 Jul 14, 2015 9:31 AM
    faststocks7 faststocks7 Jul 15, 2015 11:59 PM Flag

    Ten cents is only a market cap of about 2 times 2014 revenues which is still very cheap.

    With new management and increasing revenues with accelerated growth I'm guessing shares will be selling closer to $.50 before year end and that is a huge percentage gain no matter what all these idiot bashers are saying.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Something good is obviously happening that is causing buying to spike. Charts signal move beyond $0.10 in very near term.

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move up and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

AXGN
6.66+0.08(+1.22%)12:51 PMEDT